SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : ahhaha's ahs -- Ignore unavailable to you. Want to Upgrade?

To: Ahda who wrote (2978)9/26/2001 12:15:58 PM
From: ElsewhereRespond to of 24758
 
Bayer Pharmaceutical Division

Bayer trades as BAYZY. They are planning to go to the NYSE in February 2002:
August 16, 2001: Bayer postpones listing on Wall Street
194.231.159.252

BASF is already listed as BF; former Hoechst is now Aventis (AVE) after the merger with RPR. The German Schering (SHR) is a pure pharma co; if you prefer biotech there is Qiagen (QGENF).



To: Ahda who wrote (2978)1/22/2002 1:27:21 PM
From: ElsewhereRead Replies (1) | Respond to of 24758
 
Bayer Pharmaceutical Division

Starting Thursday Bayer will be listed on the NYSE. For details see news.bayer.com

On a price/sales basis BAY is much cheaper than US pharmaceutical companies, about 0.75 compared to MRK's 2.9 or PFE's 8.2. If BAY ever manages to approach US-style margins the stock won't stay at the $33 level planned for the NYSE debut.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News